Si prevede che il mercato dei farmaci per l'asma raggiungerà i 34.136,10 milioni di dollari nel 2028 rispetto ai 24.239,17 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 5,0% nel corso del 2021-2028.
L'asma è una malattia polmonare che colpisce persone di tutte le età. Produce respiro sibilante e rende difficile la respirazione. L'esposizione a un'allergia o a una sostanza irritante, infezioni, esercizio fisico, stress emotivo e altre condizioni sono tutti potenziali fattori scatenanti. Quando i sintomi dell’asma diventano insopportabili si verifica un attacco d’asma. Gli attacchi possono verificarsi dal nulla e vanno da lievi a pericolosi per la vita. L’asma viene gestita con inalatori di emergenza per trattare i sintomi e inalatori di controllo che prevengono i sintomi. I casi gravi possono richiedere inalatori ad azione prolungata che mantengono aperte le vie aeree (formoterolo, salmeterolo, tiotropio) e steroidi inalatori. I farmaci per l'asma sono disponibili in diverse forme, tra cui compresse, iniezioni, liquidi e inalatori, e rientrano in due gruppi, come broncodilatatori e antinfiammatori.
Il mercato dei farmaci per l'asma è segmentato in base ai farmaci. , via di somministrazione, canale di distribuzione e geografia. Il mercato, in base alla geografia, è ampiamente segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e Sud & America Centrale. Il rapporto sul mercato dei farmaci per l’asma offre approfondimenti e analisi approfondite del mercato, sottolineando parametri quali dimensioni del mercato, tendenze e dinamiche; progressi tecnologici nel mercato; e l'analisi del panorama competitivo dei principali attori del mercato dei farmaci per l'asma.
Approfondimenti strategici
Alcuni fattori come le crescenti implicazioni ambientali e l'impatto ambientale. Si prevede che le implicazioni genetiche dell’inquinamento atmosferico, la maggiore vulnerabilità in specifici gruppi etnici, la crescente esposizione a particelle grossolane, la crescente prevalenza di disturbi fisiologici che ospitano l’asma avranno un impatto significativo a breve, medio e lungo termine sul mercato dei farmaci per l’asma in i prossimi anni. Tuttavia, i bisogni medici insoddisfatti e la mancanza di aderenza al trattamento ostacolano la crescita del mercato. Il rapporto di mercato identifica opportunità e tendenze future del mercato che possono avere possibili impatti sulla crescita del mercato.
Regioni redditizie nel mercato dei farmaci per l'asma
Approfondimenti sul mercato
Crescenti implicazioni ambientali e protezione ambientale Implicazioni genetiche dell'inquinamento atmosferico
L'asma è una condizione respiratoria cronica caratterizzata da restrizione fluttuante del flusso aereo, iperreattività bronchiale e infiammazione delle vie aeree. Secondo un documento di revisione intitolato "Impatto dell'inquinamento atmosferico sugli esiti dell'asma" da Tiotiu et.al., l’inquinamento atmosferico ha ostacolato gli esiti dell’asma negli adulti e nei bambini. L'inquinamento atmosferico dovuto al traffico, il biossido di azoto (NO2) e il fumo passivo (SHS) sono tutti fattori di rischio sostanziali per lo sviluppo dell'asma nei bambini. I sintomi dell'asma, le riacutizzazioni e la ridotta funzionalità polmonare possono essere innescati dall'esposizione all'inquinamento esterno.
Negli Stati Uniti, l'esposizione all'inquinamento atmosferico continua a essere associata all'asma. Questa condizione respiratoria cronica grave e pericolosa per la vita incide sulla qualità della vita di oltre 23 milioni di cittadini americani. L’inquinamento atmosferico può aggravare i sintomi dell’asma, scatenando attacchi di asma tra le persone. I bambini affetti da asma, che colpisce circa 6 milioni di bambini negli Stati Uniti, sono particolarmente vulnerabili all'inquinamento.
Un nuovo studio finanziato dall'Environmental Protection Agency (EPA) ha analizzato il legame tra inquinamento atmosferico e asma. Sebbene gli esperti non siano in grado di determinare l’agente principale che causa l’asma a causa dell’inquinamento atmosferico, le prove suggeriscono che esso sopprime i geni che controllano il sistema immunitario per distinguere tra un allergene e una sostanza estranea pericolosa, come un virus o un batterio. Il sistema immunitario quindi va in overdrive, innescando una reazione infiammatoria indipendentemente dal fatto che il farmaco sia tossico, con conseguente asma.
I ricercatori del Children's Center dell'Università di Stanford hanno studiato l'effetto dell'inquinamento atmosferico su due geni coinvolti nella tolleranza immunologica. nei bambini provenienti da una zona con alti livelli di inquinamento. Hanno scoperto che l'esposizione a breve e lungo termine a quantità elevate di monossido di carbonio (CO), NO2 e PM2,5 (particolato) era collegata a cambiamenti in questi due geni, che causavano l’asma. Questi risultati si sono concentrati sugli impatti epigenetici dell'esposizione all'inquinamento atmosferico e potrebbero aiutare nello sviluppo di farmaci preventivi per l'asma.
Ognuna di queste ricerche sull'asma ha migliorato la comprensione dell'asma nei bambini e ha fornito informazioni cruciali all'EPA che possono essere utilizzati per proteggere la salute umana e l’ambiente. Attraverso questi lavori di ricerca, la scoperta e lo sviluppo di farmaci per l'asma vengono accelerati, il che sta guidando il mercato dei farmaci per l'asma.
Approfondimenti basati sul tipo di farmaco
Il mercato globale dei farmaci per l'asma, basato sui farmaci, è diviso in farmaci di rapido sollievo e farmaci di controllo a lungo termine. Si prevede che il segmento dei farmaci per il controllo a lungo termine deterrà una quota maggiore del mercato nei prossimi anni. Tuttavia, si prevede che il segmento dei farmaci per il sollievo rapido registrerà un CAGR più elevato durante il periodo di previsione.
Mercato dei farmaci per l'asma, per farmaco: 2021 e 2028
Percorso di approfondimenti basati sulla somministrazione
In base alla via di somministrazione, il mercato dei farmaci per l'asma è segmentato in siringhe/flaconi preriempiti per inalazione, e altri. Il segmento dell’inalazione deteneva la quota maggiore del mercato nel 2021 e si prevede che deterrà una quota significativa durante il periodo di previsione. Tuttavia, si prevede che il segmento delle siringhe/flaconi preriempiti registrerà il CAGR più elevato dal 2021 al 2028.
Approfondimenti basati sul canale di distribuzione
In base al canale di distribuzione, il mercato dei farmaci per l'asma è segmentato nelle farmacie online, nelle farmacie ospedaliere e nelle farmacie al dettaglio. Si prevede che il segmento delle farmacie al dettaglio deterrà la quota maggiore del mercato durante il periodo di previsione. Tuttavia, si prevede che il segmento delle farmacie online registrerà il CAGR più elevato nel periodo 2021-2028.
Varie aziende che operano nel mercato dei farmaci per l'asma adottano strategie come lancio di prodotti, fusioni e acquisizioni, collaborazioni, innovazioni di prodotto e espansioni del portafoglio prodotti per espandere la propria presenza in tutto il mondo, mantenere un marchio e soddisfare le crescenti richieste dei consumatori. Alcuni dei principali attori presenti sul mercato sono AstraZeneca; Teva Industrie Farmaceutiche Ltd.; GlaxoSmithKline PLC; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Koninklijke Philips NV; Sanofi; Pfizer Inc.; Novartis AG; e Abbott.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range in severity from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids. Asthma drugs come in several forms, including tablets, injections, liquids, and inhalers; and it falls into two groups: bronchodilators and anti-inflammatories.
The global asthma drugs market is being driven by factors such as growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and the growing prevalence of physiological disorders harboring asthma.
The unmet medical needs and the lack of treatment adherence are the leading restraints that will hinder the asthma drugs market growth.
The asthma drugs market comprises of players that include AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Koninklijke Philips N.V., Sanofi, Pfizer Inc., Novartis AG, and Abbott are among others.
The asthma drugs market on the basis of medication is bifurcated into quick relief medications and long-term control medications. In 2021, the long-term control medications segment accounted for a larger share in the global asthma drugs market.
On the basis of route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment is expected to hold the largest share from 2021 to 2028. However, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period.
The List of Companies - Asthma Drugs Market
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Koninklijke Philips NV
- Sanofi
- Pfizer Inc.
- Novartis AG
- Abbott
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)